Patent · US Active

Treatment for the non alcoholic steatohepatitis and fibrosis

US11324743B2 · kind B2 · utility

0Cited by

6References

13Claims

0Family size

Assignee

METABOLYS · FR

Inventors

Gabriel Baverel · Caluire-et-Cuire, FR
Gerard Moinet · Orsay, FR

Key dates

Filing date	Aug 3, 2017
Grant date	May 10, 2022
Priority date	—
Expiry date	Aug 3, 2037

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P1/16
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compounds of formula (I) or their enantiomers, diastereoisomers thereof and the addition salts thereof with pharmaceutically acceptable bases or acids, for use for the prevention or treatment, preferably treatment, of NASH.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.